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Conclusions: Ferex can be used as an in-vivo tracking
agent of MSCs in PAAA models.
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Objectives: Bone marrow cells(BMCs) that include
stem and progenitor cells are widely accepted to apply to
patients suffering with peripheral arterial disease(PAD) as a
therapeutic approach to induce neo- vascularization. How-
ever, the critical paracrine effects are still unclear to admin-
istrate BMCs. We focused macrophages that regulate
VEGF, especially in VEGF-C.
Methods: Male C57BL/6 mice were administered
intramuscular injections of PBS control, unselected BMCs,
CD11b, CD11b- cells from BMCs, and recombinant
VEGF-C to ischemic model of hind limb. As the evalua-
tions, perfusion was measured with a laser Doppler scan-
ning that were collected on days 0,1, 3, 7, 14, 21, and 28
including a functional assay such as catwalk in parallel.
Capillary density was determined by direct counting vessels
positive with Von Willebrand factor at individual time
points. Moreover, lymphangiogenesis was assessed as
LYVE-1 positive cells.
Results: Post-ischemic recovery of hind limb perfu-
sion was significantly improved in BMCs, CD11b and
VEGF-C group to compare with control group as the
result of laser Doppler scanning. In the functional assay,
VEGF-C group dramatically recovered compared to
control group. The capillary/myofiber ratio in the thigh
muscle was higher in BMCs and VEGF-C group than in
control group same as LYVE-1 positive cells. Further-
more, the expression of VEGF, VEGF-C, their receptors
of mRNA and Protein were involved predominately in
CD11b cells.
Conclusions: CD11b macrophages play the critical
role for angiogenesis and lymphangiogenesis in the murine
model of hind limb ischemia. Consequently, recombinant
VEGF-C accelerates the recovery and may be a promising
therapeutic strategy for PAD patients.
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Performance of a Nanocomposite Polymer Small Di-
ameter Bypass Graft in a Log-term Sheep Model
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Objectives: To evaluate in vivo performance of small
diameter grafts (5 mm) made from a compliant, thrombo-
resistant, bio-durable POSS-PCU polymer in a challenging
ovine model.
Methods: POSS-PCU grafts were implanted in 12
sheep as interposition grafts in left common carotid artery
(LCA) (GLP Regulations; all had daily 75 mg aspirin).
Duplex imaging was performed on days 1, 7, 14 and then
monthly. Comparison wasmade with 5mm ePTFE grafts as
control (n6 sheep) and in all animals with the unoperated
right common carotid artery (RCA). Flow rates and graft
compliance were measured in all target vessels/grafts. Pat-
ent grafts were explanted after 9months. Following explan-
tation, all grafts were assessed independently by histological
analysis.
Results: Animal 8 did not survive the anaesthetic and
grafts 1 and 9 thrombosed immediately; these two carot-
ids exhibited irreversible spasm during surgery. Animal 7
had tortuous LCA with gross diameter mismatch and
thrombosed on day 14. Graft 4 blocked on day 15 and
Graft 3 on day 59. Six grafts were patent for 9 months.
Patency rates were 67% at 9 months and 78% at 6 weeks.
The ePTFE grafts in comparison had all occluded by 1
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